ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Implantable Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-0Z17851
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Implantable Heart Failure Devices Market Research Report 2024
BUY CHAPTERS

Global Implantable Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0Z17851
Report
October 2025
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Medtronic Inc
Jarvik Heart
Abiomed Inc
Boston Scientific
Impulse Dynamics
SynCardia
Berlin Heart
Covia Medica
V-Wave
Evaheart
BrioHealth Solutions
Hanyu Medical
NewMed Medical
Valgen Medtech

Implantable Heart Failure Devices Market

The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
From a downstream perspective, GradeⅠ- Ⅳ accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Implantable Heart Failure Devices leading manufacturers including Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Implantable Heart Failure Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Implantable Heart Failure Devices Market Report

Report Metric Details
Report Name Implantable Heart Failure Devices Market
Segment by Type
  • Mechanical Assistance Type
  • Electrical Related Technology
  • Structural Improvement Type
Segment by Application
  • GradeⅠ- Ⅳ
  • Grade Ⅱ- Ⅳ
  • Grade Ⅲ -IV
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, Evaheart, BrioHealth Solutions, Hanyu Medical, NewMed Medical, Valgen Medtech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Implantable Heart Failure Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Implantable Heart Failure Devices Market report?

Ans: The main players in the Implantable Heart Failure Devices Market are Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, Evaheart, BrioHealth Solutions, Hanyu Medical, NewMed Medical, Valgen Medtech

What are the Application segmentation covered in the Implantable Heart Failure Devices Market report?

Ans: The Applications covered in the Implantable Heart Failure Devices Market report are GradeⅠ- Ⅳ, Grade Ⅱ- Ⅳ, Grade Ⅲ -IV

What are the Type segmentation covered in the Implantable Heart Failure Devices Market report?

Ans: The Types covered in the Implantable Heart Failure Devices Market report are Mechanical Assistance Type, Electrical Related Technology, Structural Improvement Type

1 Study Coverage
1.1 Introduction to Implantable Heart Failure Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Implantable Heart Failure Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mechanical Assistance Type
1.2.3 Electrical Related Technology
1.2.4 Structural Improvement Type
1.3 Market Segmentation by Application
1.3.1 Global Implantable Heart Failure Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 GradeⅠ- Ⅳ
1.3.3 Grade Ⅱ- Ⅳ
1.3.4 Grade Ⅲ -IV
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Implantable Heart Failure Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Implantable Heart Failure Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Implantable Heart Failure Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Implantable Heart Failure Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Implantable Heart Failure Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Implantable Heart Failure Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mechanical Assistance Type Market Size by Manufacturers
3.5.2 Electrical Related Technology Market Size by Manufacturers
3.5.3 Structural Improvement Type Market Size by Manufacturers
3.6 Global Implantable Heart Failure Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Implantable Heart Failure Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Implantable Heart Failure Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Implantable Heart Failure Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Implantable Heart Failure Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Implantable Heart Failure Devices Sales and Revenue by Type (2020-2031)
6.4 North America Implantable Heart Failure Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Implantable Heart Failure Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Implantable Heart Failure Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Implantable Heart Failure Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Implantable Heart Failure Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Implantable Heart Failure Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Implantable Heart Failure Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Implantable Heart Failure Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Implantable Heart Failure Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Implantable Heart Failure Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Implantable Heart Failure Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Implantable Heart Failure Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Implantable Heart Failure Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Implantable Heart Failure Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.1.4 Abbott Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Implantable Heart Failure Devices Sales by Product in 2024
11.1.6 Abbott Implantable Heart Failure Devices Sales by Application in 2024
11.1.7 Abbott Implantable Heart Failure Devices Sales by Geographic Area in 2024
11.1.8 Abbott Implantable Heart Failure Devices SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.2.4 Medtronic Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Implantable Heart Failure Devices Sales by Product in 2024
11.2.6 Medtronic Implantable Heart Failure Devices Sales by Application in 2024
11.2.7 Medtronic Implantable Heart Failure Devices Sales by Geographic Area in 2024
11.2.8 Medtronic Implantable Heart Failure Devices SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Jarvik Heart
11.3.1 Jarvik Heart Corporation Information
11.3.2 Jarvik Heart Business Overview
11.3.3 Jarvik Heart Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.3.4 Jarvik Heart Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Jarvik Heart Implantable Heart Failure Devices Sales by Product in 2024
11.3.6 Jarvik Heart Implantable Heart Failure Devices Sales by Application in 2024
11.3.7 Jarvik Heart Implantable Heart Failure Devices Sales by Geographic Area in 2024
11.3.8 Jarvik Heart Implantable Heart Failure Devices SWOT Analysis
11.3.9 Jarvik Heart Recent Developments
11.4 Abiomed
11.4.1 Abiomed Corporation Information
11.4.2 Abiomed Business Overview
11.4.3 Abiomed Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.4.4 Abiomed Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Abiomed Implantable Heart Failure Devices Sales by Product in 2024
11.4.6 Abiomed Implantable Heart Failure Devices Sales by Application in 2024
11.4.7 Abiomed Implantable Heart Failure Devices Sales by Geographic Area in 2024
11.4.8 Abiomed Implantable Heart Failure Devices SWOT Analysis
11.4.9 Abiomed Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Corporation Information
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.5.4 Boston Scientific Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Boston Scientific Implantable Heart Failure Devices Sales by Product in 2024
11.5.6 Boston Scientific Implantable Heart Failure Devices Sales by Application in 2024
11.5.7 Boston Scientific Implantable Heart Failure Devices Sales by Geographic Area in 2024
11.5.8 Boston Scientific Implantable Heart Failure Devices SWOT Analysis
11.5.9 Boston Scientific Recent Developments
11.6 Impulse Dynamics
11.6.1 Impulse Dynamics Corporation Information
11.6.2 Impulse Dynamics Business Overview
11.6.3 Impulse Dynamics Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.6.4 Impulse Dynamics Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Impulse Dynamics Recent Developments
11.7 SynCardia
11.7.1 SynCardia Corporation Information
11.7.2 SynCardia Business Overview
11.7.3 SynCardia Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.7.4 SynCardia Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 SynCardia Recent Developments
11.8 Berlin Heart
11.8.1 Berlin Heart Corporation Information
11.8.2 Berlin Heart Business Overview
11.8.3 Berlin Heart Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.8.4 Berlin Heart Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Berlin Heart Recent Developments
11.9 Covia Medica
11.9.1 Covia Medica Corporation Information
11.9.2 Covia Medica Business Overview
11.9.3 Covia Medica Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.9.4 Covia Medica Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Covia Medica Recent Developments
11.10 V-Wave
11.10.1 V-Wave Corporation Information
11.10.2 V-Wave Business Overview
11.10.3 V-Wave Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.10.4 V-Wave Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 V-Wave Recent Developments
11.11 Evaheart
11.11.1 Evaheart Corporation Information
11.11.2 Evaheart Business Overview
11.11.3 Evaheart Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.11.4 Evaheart Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Evaheart Recent Developments
11.12 BrioHealth Solutions
11.12.1 BrioHealth Solutions Corporation Information
11.12.2 BrioHealth Solutions Business Overview
11.12.3 BrioHealth Solutions Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.12.4 BrioHealth Solutions Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 BrioHealth Solutions Recent Developments
11.13 Hanyu Medical
11.13.1 Hanyu Medical Corporation Information
11.13.2 Hanyu Medical Business Overview
11.13.3 Hanyu Medical Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.13.4 Hanyu Medical Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Hanyu Medical Recent Developments
11.14 NewMed Medical
11.14.1 NewMed Medical Corporation Information
11.14.2 NewMed Medical Business Overview
11.14.3 NewMed Medical Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.14.4 NewMed Medical Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 NewMed Medical Recent Developments
11.15 Valgen Medtech
11.15.1 Valgen Medtech Corporation Information
11.15.2 Valgen Medtech Business Overview
11.15.3 Valgen Medtech Implantable Heart Failure Devices Product Models, Descriptions and Specifications
11.15.4 Valgen Medtech Implantable Heart Failure Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Valgen Medtech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Implantable Heart Failure Devices Industry Chain
12.2 Implantable Heart Failure Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Implantable Heart Failure Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Implantable Heart Failure Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Implantable Heart Failure Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Implantable Heart Failure Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Abbott
Medtronic Inc
Jarvik Heart
Abiomed Inc
Boston Scientific
Impulse Dynamics
SynCardia
Berlin Heart
Covia Medica
V-Wave
Evaheart
BrioHealth Solutions
Hanyu Medical
NewMed Medical
Valgen Medtech
List of Tables
 Table 1. Global Implantable Heart Failure Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Implantable Heart Failure Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Implantable Heart Failure Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Implantable Heart Failure Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Implantable Heart Failure Devices Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Implantable Heart Failure Devices Sales by Region (2020-2025) & (Units)
 Table 8. Global Implantable Heart Failure Devices Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Implantable Heart Failure Devices Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Implantable Heart Failure Devices Sales Share by Manufacturers (2020-2025)
 Table 12. Global Implantable Heart Failure Devices Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Implantable Heart Failure Devices Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Implantable Heart Failure Devices by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Heart Failure Devices as of 2024)
 Table 16. Global Implantable Heart Failure Devices Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Implantable Heart Failure Devices Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers Implantable Heart Failure Devices Manufacturing Base and Headquarters
 Table 19. Global Implantable Heart Failure Devices Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Implantable Heart Failure Devices Sales by Type (2020-2025) & (Units)
 Table 23. Global Implantable Heart Failure Devices Sales by Type (2026-2031) & (Units)
 Table 24. Global Implantable Heart Failure Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Implantable Heart Failure Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Implantable Heart Failure Devices ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Implantable Heart Failure Devices Sales by Application (2020-2025) & (Units)
 Table 29. Global Implantable Heart Failure Devices Sales by Application (2026-2031) & (Units)
 Table 30. Implantable Heart Failure Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Implantable Heart Failure Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Implantable Heart Failure Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Implantable Heart Failure Devices ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Implantable Heart Failure Devices Growth Accelerators and Market Barriers
 Table 37. North America Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Implantable Heart Failure Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Implantable Heart Failure Devices Growth Accelerators and Market Barriers
 Table 40. Europe Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Implantable Heart Failure Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Implantable Heart Failure Devices Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Implantable Heart Failure Devices Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Implantable Heart Failure Devices Investment Opportunities and Key Challenges
 Table 47. Central and South America Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Implantable Heart Failure Devices Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Implantable Heart Failure Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Abbott Corporation Information
 Table 51. Abbott Description and Major Businesses
 Table 52. Abbott Product Models, Descriptions and Specifications
 Table 53. Abbott Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. Abbott Sales Value Proportion by Product in 2024
 Table 55. Abbott Sales Value Proportion by Application in 2024
 Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 57. Abbott Implantable Heart Failure Devices SWOT Analysis
 Table 58. Abbott Recent Developments
 Table 59. Medtronic Corporation Information
 Table 60. Medtronic Description and Major Businesses
 Table 61. Medtronic Product Models, Descriptions and Specifications
 Table 62. Medtronic Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Medtronic Sales Value Proportion by Product in 2024
 Table 64. Medtronic Sales Value Proportion by Application in 2024
 Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
 Table 66. Medtronic Implantable Heart Failure Devices SWOT Analysis
 Table 67. Medtronic Recent Developments
 Table 68. Jarvik Heart Corporation Information
 Table 69. Jarvik Heart Description and Major Businesses
 Table 70. Jarvik Heart Product Models, Descriptions and Specifications
 Table 71. Jarvik Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Jarvik Heart Sales Value Proportion by Product in 2024
 Table 73. Jarvik Heart Sales Value Proportion by Application in 2024
 Table 74. Jarvik Heart Sales Value Proportion by Geographic Area in 2024
 Table 75. Jarvik Heart Implantable Heart Failure Devices SWOT Analysis
 Table 76. Jarvik Heart Recent Developments
 Table 77. Abiomed Corporation Information
 Table 78. Abiomed Description and Major Businesses
 Table 79. Abiomed Product Models, Descriptions and Specifications
 Table 80. Abiomed Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Abiomed Sales Value Proportion by Product in 2024
 Table 82. Abiomed Sales Value Proportion by Application in 2024
 Table 83. Abiomed Sales Value Proportion by Geographic Area in 2024
 Table 84. Abiomed Implantable Heart Failure Devices SWOT Analysis
 Table 85. Abiomed Recent Developments
 Table 86. Boston Scientific Corporation Information
 Table 87. Boston Scientific Description and Major Businesses
 Table 88. Boston Scientific Product Models, Descriptions and Specifications
 Table 89. Boston Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. Boston Scientific Sales Value Proportion by Product in 2024
 Table 91. Boston Scientific Sales Value Proportion by Application in 2024
 Table 92. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 93. Boston Scientific Implantable Heart Failure Devices SWOT Analysis
 Table 94. Boston Scientific Recent Developments
 Table 95. Impulse Dynamics Corporation Information
 Table 96. Impulse Dynamics Description and Major Businesses
 Table 97. Impulse Dynamics Product Models, Descriptions and Specifications
 Table 98. Impulse Dynamics Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 99. Impulse Dynamics Recent Developments
 Table 100. SynCardia Corporation Information
 Table 101. SynCardia Description and Major Businesses
 Table 102. SynCardia Product Models, Descriptions and Specifications
 Table 103. SynCardia Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 104. SynCardia Recent Developments
 Table 105. Berlin Heart Corporation Information
 Table 106. Berlin Heart Description and Major Businesses
 Table 107. Berlin Heart Product Models, Descriptions and Specifications
 Table 108. Berlin Heart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 109. Berlin Heart Recent Developments
 Table 110. Covia Medica Corporation Information
 Table 111. Covia Medica Description and Major Businesses
 Table 112. Covia Medica Product Models, Descriptions and Specifications
 Table 113. Covia Medica Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 114. Covia Medica Recent Developments
 Table 115. V-Wave Corporation Information
 Table 116. V-Wave Description and Major Businesses
 Table 117. V-Wave Product Models, Descriptions and Specifications
 Table 118. V-Wave Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 119. V-Wave Recent Developments
 Table 120. Evaheart Corporation Information
 Table 121. Evaheart Description and Major Businesses
 Table 122. Evaheart Product Models, Descriptions and Specifications
 Table 123. Evaheart Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 124. Evaheart Recent Developments
 Table 125. BrioHealth Solutions Corporation Information
 Table 126. BrioHealth Solutions Description and Major Businesses
 Table 127. BrioHealth Solutions Product Models, Descriptions and Specifications
 Table 128. BrioHealth Solutions Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 129. BrioHealth Solutions Recent Developments
 Table 130. Hanyu Medical Corporation Information
 Table 131. Hanyu Medical Description and Major Businesses
 Table 132. Hanyu Medical Product Models, Descriptions and Specifications
 Table 133. Hanyu Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 134. Hanyu Medical Recent Developments
 Table 135. NewMed Medical Corporation Information
 Table 136. NewMed Medical Description and Major Businesses
 Table 137. NewMed Medical Product Models, Descriptions and Specifications
 Table 138. NewMed Medical Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 139. NewMed Medical Recent Developments
 Table 140. Valgen Medtech Corporation Information
 Table 141. Valgen Medtech Description and Major Businesses
 Table 142. Valgen Medtech Product Models, Descriptions and Specifications
 Table 143. Valgen Medtech Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 144. Valgen Medtech Recent Developments
 Table 145. Key Raw Materials Distribution
 Table 146. Raw Materials Key Suppliers
 Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 148. Milestones in Production Technology Evolution
 Table 149. Distributors List
 Table 150. Market Trends and Market Evolution
 Table 151. Market Drivers and Opportunities
 Table 152. Market Challenges, Risks, and Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources


List of Figures
 Figure 1. Implantable Heart Failure Devices Product Picture
 Figure 2. Global Implantable Heart Failure Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Mechanical Assistance Type Product Picture
 Figure 4. Electrical Related Technology Product Picture
 Figure 5. Structural Improvement Type Product Picture
 Figure 6. Global Implantable Heart Failure Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. GradeⅠ- Ⅳ
 Figure 8. Grade Ⅱ- Ⅳ
 Figure 9. Grade Ⅲ -IV
 Figure 10. Implantable Heart Failure Devices Report Years Considered
 Figure 11. Global Implantable Heart Failure Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Implantable Heart Failure Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Implantable Heart Failure Devices Revenue Market Share by Region (2020-2031)
 Figure 15. Global Implantable Heart Failure Devices Sales (2020-2031) & (Units)
 Figure 16. Global Implantable Heart Failure Devices Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Implantable Heart Failure Devices Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Implantable Heart Failure Devices Sales Volume Market Share in 2024
 Figure 19. Global Implantable Heart Failure Devices Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Mechanical Assistance Type Revenue Market Share by Manufacturer in 2024
 Figure 22. Electrical Related Technology Revenue Market Share by Manufacturer in 2024
 Figure 23. Structural Improvement Type Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Implantable Heart Failure Devices Sales Market Share by Type (2020-2031)
 Figure 25. Global Implantable Heart Failure Devices Revenue Market Share by Type (2020-2031)
 Figure 26. Global Implantable Heart Failure Devices Sales Market Share by Application (2020-2031)
 Figure 27. Global Implantable Heart Failure Devices Revenue Market Share by Application (2020-2031)
 Figure 28. North America Implantable Heart Failure Devices Sales YoY (2020-2031) & (Units)
 Figure 29. North America Implantable Heart Failure Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Implantable Heart Failure Devices Sales Revenue (US$ Million) in 2024
 Figure 31. North America Implantable Heart Failure Devices Sales Volume (Units) by Type (2020- 2031)
 Figure 32. North America Implantable Heart Failure Devices Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Implantable Heart Failure Devices Sales Volume (Units) by Application (2020-2031)
 Figure 34. North America Implantable Heart Failure Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Implantable Heart Failure Devices Sales YoY (2020-2031) & (Units)
 Figure 39. Europe Implantable Heart Failure Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Implantable Heart Failure Devices Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Implantable Heart Failure Devices Sales Volume (Units) by Type (2020-2031)
 Figure 42. Europe Implantable Heart Failure Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Implantable Heart Failure Devices Sales Volume (Units) by Application (2020-2031)
 Figure 44. Europe Implantable Heart Failure Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 46. France Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Implantable Heart Failure Devices Sales YoY (2020-2031) & (Units)
 Figure 51. Asia-Pacific Implantable Heart Failure Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Implantable Heart Failure Devices Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Implantable Heart Failure Devices Sales Volume (Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Implantable Heart Failure Devices Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Implantable Heart Failure Devices Sales Volume (Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Implantable Heart Failure Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 61. India Implantable Heart Failure Devices Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Implantable Heart Failure Devices Sales YoY (2020-2031) & (Units)
 Figure 63. Central and South America Implantable Heart Failure Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Implantable Heart Failure Devices Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Implantable Heart Failure Devices Sales Volume (Units) by Type (2021-2031)
 Figure 66. Central and South America Implantable Heart Failure Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Implantable Heart Failure Devices Sales Volume (Units) by Application (2020-2031)
 Figure 68. Central and South America Implantable Heart Failure Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Implantable Heart Failure Devices Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Implantable Heart Failure Devices Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Implantable Heart Failure Devices Sales YoY (2020-2031) & (Units)
 Figure 72. Middle East and Africa Implantable Heart Failure Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Implantable Heart Failure Devices Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Implantable Heart Failure Devices Sales Volume (Units) by Type (2021-2031)
 Figure 75. South America Implantable Heart Failure Devices Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Implantable Heart Failure Devices Sales Volume (Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Implantable Heart Failure Devices Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Implantable Heart Failure Devices Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Implantable Heart Failure Devices Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Implantable Heart Failure Devices Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Implantable Heart Failure Devices Revenue (2020-2025) & (US$ Million)
 Figure 82. Implantable Heart Failure Devices Industry Chain Mapping
 Figure 83. Regional Implantable Heart Failure Devices Manufacturing Base Distribution (%)
 Figure 84. Global Implantable Heart Failure Devices Production Market Share by Region (2020-2031)
 Figure 85. Implantable Heart Failure Devices Production Process
 Figure 86. Regional Implantable Heart Failure Devices Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Heart Failure Devices Market Research Report 2024
Global Implantable Heart Pump Market Research Report 2024
Global Heart Failure Monitoring System Market Research Report 2024
Global Heart Failure Testing Market Research Report 2024
Global Cardiac Implantable Device Market Research Report 2024
Global Heart Failure Therapeutics Market Research Report 2024
Global Cardiac Monitoring and Cardiac Rhythm Management Device Market Research Report 2024
Global Implantable Cardiac Resynchronization Therapy Equipment Market Research Report 2024
Global Implantable Heart Assist Pump Market Research Report 2024
Global LVAD Market Research Report 2024
Global Implantable Cardiac Rhythm Management Device Market Insights Forecast to 2030
Global Implantable Cardiovascular Devices Market Research Report 2024
Global Cardiac Resynchronization Therapy Devices Market Insights Forecast to 2030
Global Heart Failure Treatment Market Insights Forecast to 2030
Global Cardiac Rhythm Monitoring Devices Market Research Report 2025
Global Artificial Heart Market Research Report 2024
Global Cardiac Implants Market Research Report 2024
Global Afib Heart Devices Market Research Report 2025
Implantable Heart Pacemaker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Heart Failure CHF Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions